Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Dosing Strategies for Smoking Cessation
NCT00150254Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline in nicotine dependence (5 arms), sponsored by Pfizer. Primary endpoint: Continuous Quit Rate. Started Sep 2001; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00150254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150254.